Clinical Trial Update: The Effect of Benralizumab on Exercise-induced Bronchoconstriction [Phase 3]

View source ↗

Summary

This is an update on a Phase 3 trial evaluating benralizumab for exercise-induced bronchoconstriction in asthma, with the trial status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Exercise-induced Bronchoconstriction

Drugs mentioned

• FASENRA (BENRALIZUMAB)

Snippet

Sponsor: Louis-Philippe Boulet | Conditions: Asthma, Exercise-Induced | Phase 3 | Status: UNKNOWN